Wellcome Open Research,
Journal Year:
2021,
Volume and Issue:
6, P. 16 - 16
Published: Jan. 28, 2021
Drugs
whose
targets
have
genetic
evidence
to
support
efficacy
and
safety
are
more
likely
be
approved
after
clinical
development.
In
this
paper,
we
provide
an
overview
of
how
natural
sequence
variation
in
the
genes
that
encode
drug
can
used
Mendelian
randomization
analyses
offer
insight
into
mechanism-based
adverse
effects.
Large
databases
summary
level
association
data
increasingly
available
leveraged
identify
validate
variants
serve
as
proxies
for
target
perturbation.
As
with
all
empirical
research,
has
limitations
including
confounding,
its
consideration
lifelong
effects,
issues
related
heterogeneity
across
different
tissues
populations.
When
appropriately
applied,
provides
a
useful
framework
using
population
improve
success
rates
development
pipeline.
Results
from
genome-wide
association
studies
(GWAS)
can
be
used
to
infer
causal
relationships
between
phenotypes,
using
a
strategy
known
as
2-sample
Mendelian
randomization
(2SMR)
and
bypassing
the
need
for
individual-level
data.
However,
2SMR
methods
are
evolving
rapidly
GWAS
results
often
insufficiently
curated,
undermining
efficient
implementation
of
approach.
We
therefore
developed
MR-Base
(
http://www.mrbase.org
):
platform
that
integrates
curated
database
complete
(no
restrictions
according
statistical
significance)
with
an
application
programming
interface,
web
app
R
packages
automate
2SMR.
The
software
includes
several
sensitivity
analyses
assessing
impact
horizontal
pleiotropy
other
violations
assumptions.
currently
comprises
11
billion
single
nucleotide
polymorphism-trait
associations
1673
is
updated
on
regular
basis.
Integrating
data
ensures
more
rigorous
hypothesis-driven
allows
millions
potential
efficiently
evaluated
in
phenome-wide
studies.
Bioinformatics,
Journal Year:
2016,
Volume and Issue:
33(2), P. 272 - 279
Published: Sept. 22, 2016
LD
score
regression
is
a
reliable
and
efficient
method
of
using
genome-wide
association
study
(GWAS)
summary-level
results
data
to
estimate
the
SNP
heritability
complex
traits
diseases,
partition
this
into
functional
categories,
genetic
correlation
between
different
phenotypes.
Because
relies
on
summary
level
data,
computationally
tractable
even
for
very
large
sample
sizes.
However,
publicly
available
GWAS
are
typically
stored
in
databases
have
formats,
making
it
difficult
apply
correlations
across
many
simultaneously.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2020,
Volume and Issue:
unknown
Published: Aug. 10, 2020
Abstract
Data
generated
by
genome-wide
association
studies
(GWAS)
are
growing
fast
with
the
linkage
of
biobank
samples
to
health
records,
and
expanding
capture
high-dimensional
molecular
phenotypes.
However
utility
these
efforts
can
only
be
fully
realised
if
their
complete
results
collected
from
heterogeneous
sources
formats,
harmonised
made
programmatically
accessible.
Here
we
present
OpenGWAS
database,
an
open
source,
access,
scalable
high-performance
cloud-based
data
infrastructure
that
imports
publishes
GWAS
summary
datasets
metadata
for
scientific
community.
Our
import
pipeline
harmonises
against
dbSNP
human
genome
reference
sequence,
generates
reports
standardises
format
metadata.
Users
access
via
a
website,
application
programming
interface,
R
Python
packages,
also
as
downloadable
files
rapidly
queried
in
high
performance
computing
environments.
currently
contains
126
billion
genetic
associations
14,582
representing
range
different
phenotypes
disease
outcomes
across
populations.
We
developed
packages
serve
conduits
between
available
analytical
tools,
enabling
Mendelian
randomization,
colocalisation
analysis,
fine
mapping,
correlation
locus
visualisation.
is
freely
accessible
at
https://gwas.mrcieu.ac.uk
,
has
been
designed
facilitate
integration
third
party
tools.
PLoS Medicine,
Journal Year:
2020,
Volume and Issue:
17(3), P. e1003062 - e1003062
Published: March 23, 2020
Background
Circulating
lipoprotein
lipids
cause
coronary
heart
disease
(CHD).
However,
the
precise
way
in
which
one
or
more
lipid-related
entities
account
for
this
relationship
remains
unclear.
Using
genetic
instruments
lipid
traits
implemented
through
multivariable
Mendelian
randomisation
(MR),
we
sought
to
compare
their
causal
roles
aetiology
of
CHD.
Methods
and
findings
We
conducted
a
genome-wide
association
study
(GWAS)
circulating
non-fasted
UK
Biobank
(UKBB)
low-density
(LDL)
cholesterol,
triglycerides,
apolipoprotein
B
identify
lipid-associated
single
nucleotide
polymorphisms
(SNPs).
data
from
CARDIoGRAMplusC4D
CHD
(consisting
60,801
cases
123,504
controls),
performed
univariable
MR
analyses.
Similar
GWAS
analyses
were
high-density
(HDL)
cholesterol
A-I.
The
apolipoproteins
UKBB
included
between
393,193
441,016
individuals
whom
mean
age
was
56.9
y
(range
39–73
y)
54.2%
women.
(standard
deviation)
concentrations
LDL
3.57
(0.87)
mmol/L
HDL
1.45
(0.38)
mmol/L,
median
triglycerides
1.50
(IQR
=
1.11)
mmol/L.
values
A-I
1.03
(0.24)
g/L
1.54
(0.27)
g/L,
respectively.
identified
multiple
independent
SNPs
associated
at
P
<
5
×
10−8
(220),
(n
255),
(440),
(534),
(440).
Between
56%–93%
each
trait
had
not
been
previously
reported
large-scale
GWASs.
Almost
half
(46%)
these
with
than
trait.
Assessed
individually
using
MR,
(odds
ratio
[OR]
1.66
per
1-standard-deviation–higher
trait;
95%
CI:
1.49–1.86;
0.001),
(OR
1.34;
1.25–1.44;
0.001)
1.73;
1.56–1.91;
effect
estimates
consistent
higher
risk
In
only
1.92;
1.31–2.81;
retained
robust
effect,
estimate
0.85;
0.57–1.27;
0.44)
reversing
that
1.12;
1.02–1.23;
0.01)
becoming
weaker.
Individual
showed
0.80;
0.75–0.86;
0.83;
0.77–0.89;
lower
CHD,
but
attenuated
substantially
null
on
accounting
B.
A
limitation
is
that,
owing
nature
metabolism,
measures
related
composition
particles
are
highly
correlated,
creating
challenge
making
exclusive
interpretations
causation
individual
components.
Conclusions
These
suggest
predominant
accounts
aetiological
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2018,
Volume and Issue:
unknown
Published: Oct. 19, 2018
Summary
While
many
disease-associated
variants
have
been
identified
through
genome-wide
association
studies,
their
downstream
molecular
consequences
remain
unclear.
To
identify
these
effects,
we
performed
cis-
and
trans-expression
quantitative
trait
locus
(eQTL)
analysis
in
blood
from
31,684
individuals
the
eQTLGen
Consortium.
We
observed
that
cis
-eQTLs
can
be
detected
for
88%
of
studied
genes,
but
they
a
different
genetic
architecture
compared
to
variants,
limiting
our
ability
use
pinpoint
causal
genes
within
susceptibility
loci.
In
contrast,
trans-eQTLs
(detected
37%
10,317
trait-associated
variants)
were
more
informative.
Multiple
unlinked
associated
same
complex
trait,
often
converged
on
trans-genes
are
known
play
central
roles
disease
etiology.
when
ascertaining
effect
polygenic
scores
calculated
1,263
study
(GWAS)
traits.
Expression
levels
13%
correlated
with
scores,
resulting
drive
American Journal of Epidemiology,
Journal Year:
2017,
Volume and Issue:
186(9), P. 1084 - 1096
Published: Jan. 30, 2017
Detailed
metabolic
profiling
in
large-scale
epidemiologic
studies
has
uncovered
novel
biomarkers
for
cardiometabolic
diseases
and
clarified
the
molecular
associations
of
established
risk
factors.
A
quantitative
metabolomics
platform
based
on
nuclear
magnetic
resonance
spectroscopy
found
widespread
use,
already
over
400,000
blood
samples.
Over
200
measures
are
quantified
per
sample;
addition
to
many
routinely
used
epidemiology,
method
simultaneously
provides
fine-grained
lipoprotein
subclass
quantification
circulating
fatty
acids,
amino
gluconeogenesis-related
metabolites,
other
molecules
from
multiple
pathways.
Here
we
focus
applications
quantifying
epidemiology.
We
highlight
characterization
factors,
use
Mendelian
randomization,
key
issues
study
design
analyses
also
detail
how
integration
data
with
genetics
can
enhance
drug
development.
discuss
why
is
becoming
epidemiology
biobanking.
Although
still
novel,
it
seems
likely
that
comprehensive
biomarker
will
contribute
etiologic
understanding
various
abilities
predict
disease
risks,
potential
translate
into
clinical
settings.